A-Alpha Bio Email Format

Biotechnology ResearchWashington, United States51-200 Employees

A-Alpha Bio is a biotechnology platform company focused on protein-protein interactions, aiming to measure, predict, and engineer these interactions at scale. Its experimental platform, AlphaSeq, enables rapid, quantitative measurement of millions of binding affinities in parallel, while its AI platform AlphaBind predicts binding strength from sequence using a comprehensive interaction database. The company collaborates with pharmaceutical and biotechnology partners through partnerships and services to enable discovery of dual-specific and molecular glue therapeutics and to generate binding and structural data at scale for AI-driven research.

Based in Seattle, Washington, the company originated as a spinout from the University of Washington’s Institute for Protein Design and operates as a mid-sized firm in the biotechnology research sector. A recent development includes a collaboration with Tamarind Bio to streamline experimental validation for AI-enabled antibody discovery.

Sign up for free to view info

Company overview Employee directory